Q3 2025 Earnings Call Transcript November 13, 2025 Operator: Greetings. Welcome to the PDS Biotechnology Corporation’s Third Quarter 2025 Earnings Conference Call. At this time, all participants are ...
Translational study shows that multiple immunological biomarkers predict the clinical activity of PDS0101 combination therapy PDS01ADC reprograms natural killer (NK) cells to possess characteristics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback